Investing Profile

Jim Tananbaum

VC

Photo of Jim Tananbaum, Managing Partner at Foresite Capital
Harvard Business School Network
253 CONNECTIONS
Massachusetts Institute of Technology Network
108 CONNECTIONS
Yale University Network
82 CONNECTIONS
cb
Foresite Capital Managing Partner
9
$668M
CompanyStageDateRound SizeTotal Raised
Series AMay 2018
Co-investors: Vijay Pande (Andreessen Horowitz), Krishna Yeshwant (GV)
Seed RoundJan 2018$12.3M
$12.3M
Series EJan 2018$58M
$89.6M
Co-investors: Jeff Clavier (Uncork Capital), Manu Kumar (K9 Ventures), Krishna Yeshwant (GV), Nat Goldhaber
Series ASep 2017$55M
$55M
Co-investors: Krishna Yeshwant (GV)
Series BMar 2015$80M
$80M
Co-investors: Stacey Seltzer (Aisling Capital)
Series BMay 2014$7M
Series BMar 2012$28M
$35M
Series DApr 2014$200M
$558M
Co-investors: Ed Mathers (New Enterprise Associates), Bryan Roberts (Venrock Ventures)
Series CJul 2013$20M
$41.5M
Co-investors: Bill Ericson (Mohr Davidow Ventures), Bill Ericson (Wildcat Ventures), Farzad Nazem
Founder and CEO Foresite Capital Management2010 - Present
Co-Founder and Managing Director PVP2 & PVP3 Prospect Venture Partners2001 - 2010
Co-Founder and Chief Executive Officer Theravance (THRX)1997 - 2000
Partner Sierra Ventures1993 - 1997
Co-Founder and CEO GelTex (acquired by Genzyme for $1.6 B)1991 - 1992
Harvard Business School mba
Harvard Medical School Doctor of Medicine (MD)
Massachusetts Institute of Technology Master of Science (M.S.) HST - information theory
Yale University BS BSEE, Math, computer science